Pfizer's Insistence On Protection Against Lawsuits In Case Of Adverse Events Stalls India Approval Of Its Covid Jab: Report
Johnson & Johnson Temporarily Pauses Covid-19 Vaccine Trials Due To 'Unexplained' Illness In Study Participant
